Literature DB >> 11368774

Distinct roles for extracellular-signal-regulated protein kinase (ERK) mitogen-activated protein kinases and phosphatidylinositol 3-kinase in the regulation of Mcl-1 synthesis.

K M Schubert1, V Duronio.   

Abstract

Alterations in the expression of various Bcl-2 family members may act as one means by which a cell's survival may be regulated. The mechanism by which cytokines regulate expression of Bcl-2 family members was examined in the haemopoietic cell line TF-1. Cytokine-induced Mcl-1 protein expression was shown to be controlled through a pathway dependent upon phosphatidylinositol 3-kinase (PI 3-kinase). The cytokine-induced increase in mRNA transcription was not dependent upon PI 3-kinase, thus dissociating the immediate-early transcription factors responsible for Mcl-1 transcription from the PI 3-kinase signalling pathway. In contrast, Mcl-1 mRNA levels were dependent upon MEK [mitogen-activated protein kinase (MAPK)/extracellular-signal-regulated protein kinase kinase] activation, suggesting a role for the Ras/MEK/MAPK pathway in Mcl-1 transcription. Activation of PI 3-kinase was shown to be necessary to stimulate Mcl-1 protein translation. This was not due to any effect on prolonging the half-life of the protein. Finally, the lipid second messenger ceramide was shown to cause a reduction in Mcl-1 protein translation, probably via its ability to inhibit protein kinase B activation, providing further clues regarding the death-inducing effect of this lipid.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11368774      PMCID: PMC1221858          DOI: 10.1042/0264-6021:3560473

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  46 in total

1.  Direct control of the Forkhead transcription factor AFX by protein kinase B.

Authors:  G J Kops; N D de Ruiter; A M De Vries-Smits; D R Powell; J L Bos; B M Burgering
Journal:  Nature       Date:  1999-04-15       Impact factor: 49.962

Review 2.  Regulation of ceramide production and apoptosis.

Authors:  R N Kolesnick; M Krönke
Journal:  Annu Rev Physiol       Date:  1998       Impact factor: 19.318

3.  Dissociation of apoptosis from proliferation, protein kinase B activation, and BAD phosphorylation in interleukin-3-mediated phosphoinositide 3-kinase signaling.

Authors:  B L Craddock; E A Orchiston; H J Hinton; M J Welham
Journal:  J Biol Chem       Date:  1999-04-09       Impact factor: 5.157

4.  Mcl-1 in transgenic mice promotes survival in a spectrum of hematopoietic cell types and immortalization in the myeloid lineage.

Authors:  P Zhou; L Qian; C K Bieszczad; R Noelle; M Binder; N B Levy; R W Craig
Journal:  Blood       Date:  1998-11-01       Impact factor: 22.113

5.  Expression of the antiapoptotic MCL1 gene product is regulated by a mitogen activated protein kinase-mediated pathway triggered through microtubule disruption and protein kinase C.

Authors:  K J Townsend; J L Trusty; M A Traupman; A Eastman; R W Craig
Journal:  Oncogene       Date:  1998-09-10       Impact factor: 9.867

6.  Regulation of cell death protease caspase-9 by phosphorylation.

Authors:  M H Cardone; N Roy; H R Stennicke; G S Salvesen; T F Franke; E Stanbridge; S Frisch; J C Reed
Journal:  Science       Date:  1998-11-13       Impact factor: 47.728

7.  Inhibition of Akt kinase by cell-permeable ceramide and its implications for ceramide-induced apoptosis.

Authors:  H Zhou; S A Summers; M J Birnbaum; R N Pittman
Journal:  J Biol Chem       Date:  1998-06-26       Impact factor: 5.157

8.  Dissociation of cytokine-induced phosphorylation of Bad and activation of PKB/akt: involvement of MEK upstream of Bad phosphorylation.

Authors:  M P Scheid; V Duronio
Journal:  Proc Natl Acad Sci U S A       Date:  1998-06-23       Impact factor: 11.205

9.  mcl-1 is an immediate-early gene activated by the granulocyte-macrophage colony-stimulating factor (GM-CSF) signaling pathway and is one component of the GM-CSF viability response.

Authors:  J R Chao; J M Wang; S F Lee; H W Peng; Y H Lin; C H Chou; J C Li; H M Huang; C K Chou; M L Kuo; J J Yen; H F Yang-Yen
Journal:  Mol Cell Biol       Date:  1998-08       Impact factor: 4.272

10.  Identification of a novel inhibitor of mitogen-activated protein kinase kinase.

Authors:  M F Favata; K Y Horiuchi; E J Manos; A J Daulerio; D A Stradley; W S Feeser; D E Van Dyk; W J Pitts; R A Earl; F Hobbs; R A Copeland; R L Magolda; P A Scherle; J M Trzaskos
Journal:  J Biol Chem       Date:  1998-07-17       Impact factor: 5.157

View more
  20 in total

Review 1.  Alveolar macrophages in pulmonary host defence the unrecognized role of apoptosis as a mechanism of intracellular bacterial killing.

Authors:  J D Aberdein; J Cole; M A Bewley; H M Marriott; D H Dockrell
Journal:  Clin Exp Immunol       Date:  2013-11       Impact factor: 4.330

2.  Cell death of bioenergetically compromised and transcriptionally challenged CLL lymphocytes by chlorinated ATP.

Authors:  Kumudha Balakrishnan; Christine M Stellrecht; Davide Genini; Mary Ayres; William G Wierda; Michael J Keating; Lorenzo M Leoni; Varsha Gandhi
Journal:  Blood       Date:  2005-02-17       Impact factor: 22.113

3.  The expression of Mcl-1 in human cervical cancer and its clinical significance.

Authors:  Ting Zhang; Chun Zhao; Liang Luo; Hua Zhao; Jing Cheng; Fei Xu
Journal:  Med Oncol       Date:  2011-06-15       Impact factor: 3.064

4.  Nurselike cells express BAFF and APRIL, which can promote survival of chronic lymphocytic leukemia cells via a paracrine pathway distinct from that of SDF-1alpha.

Authors:  Mitsufumi Nishio; Tomoyuki Endo; Nobuhiro Tsukada; Junko Ohata; Shinichi Kitada; John C Reed; Nathan J Zvaifler; Thomas J Kipps
Journal:  Blood       Date:  2005-04-28       Impact factor: 22.113

5.  PMPCB Silencing Sensitizes HCC Tumor Cells to Sorafenib Therapy.

Authors:  Jian-Feng Zheng; Shaozhong He; Zongyue Zeng; Xinqi Gu; Lei Cai; Guangying Qi
Journal:  Mol Ther       Date:  2019-07-05       Impact factor: 11.454

6.  A proteolytic fragment of Mcl-1 exhibits nuclear localization and regulates cell growth by interaction with Cdk1.

Authors:  Sarwat Jamil; Rafat Sobouti; Payman Hojabrpour; Meera Raj; Juergen Kast; Vincent Duronio
Journal:  Biochem J       Date:  2005-05-01       Impact factor: 3.857

7.  Responses in mantle cell lymphoma cells to SNS-032 depend on the biological context of each cell line.

Authors:  Rong Chen; Sherri Chubb; Tiewei Cheng; Rachael E Hawtin; Varsha Gandhi; William Plunkett
Journal:  Cancer Res       Date:  2010-07-27       Impact factor: 12.701

8.  Over-expression of interleukin-6 enhances cell survival and transformed cell growth in human malignant cholangiocytes.

Authors:  Fanyin Meng; Yoko Yamagiwa; Yoshiyuki Ueno; Tushar Patel
Journal:  J Hepatol       Date:  2005-12-13       Impact factor: 25.083

9.  Allele-Specific Role of ERBB2 in the Oncogenic Function of EGFR L861Q in EGFR-Mutant Lung Cancers.

Authors:  Hiroki Sato; Michael Offin; Daisuke Kubota; Helena A Yu; Clare Wilhelm; Shinichi Toyooka; Romel Somwar; Mark G Kris; Marc Ladanyi
Journal:  J Thorac Oncol       Date:  2020-10-07       Impact factor: 15.609

10.  Ovarian cancer ascites increase Mcl-1 expression in tumor cells through ERK1/2-Elk-1 signaling to attenuate TRAIL-induced apoptosis.

Authors:  Nadzeya Goncharenko-Khaider; Isabelle Matte; Denis Lane; Claudine Rancourt; Alain Piché
Journal:  Mol Cancer       Date:  2012-11-17       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.